haysmacintyre provided reporting accountant services for CRISM Therapeutics Corporation’s reverse takeover of Extruded Pharmaceuticals Limited.

haysmacintyre provided financial and tax due diligence, and SPA advisory services, for a property investor of affordable housing.

haysmacintyre advised on the option exercise by a UK subsidiary employee of shares in its Finnish parent company. The advice covered the employer PAYE/National Insurance Contribution withholding and reporting position, the Corporation Tax position and the employee’s personal tax and reporting position.

haysmacintyre advised on granting Enterprise Management Incentive (EMI) options to UK based employees over units in the Bermudan LLC parent entity.

haysmacintyre advised on cancellation of existing Enterprise Management Incentive (EMI) options and regrant at a lower exercise price. Whilst the business had grown fast during lockdown, its trajectory had slowed in 2023, and management wished to rebase options at a lower strike price. We successfully negotiated a significantly reduced EMI valuation to reflect this slowdown. We then advised on the tax treatment of the cancellation and regrant at the lower exercise price and provided the documentation to do this.

haysmacintyre advised on setting up an Employee Benefit Trust (EBT) for the purpose of buying out a departing founder and recycling their shares into its Company Share Option Plan (CSOP) scheme for key employees. We previously designed and implemented an Enterprise Management Incentive (EMI) plan, then the CSOP when the company became too large for EMI. We also implemented a sub-plan to grant options to contractors.

haysmacintyre provided financial and tax due diligence on Portobello Pub Company’s acquisition of Darwin & Wallace.

haysmacintyre acted as transaction support advisors to Spectra Systems Corporation (Spectra) on their acquisition of Cartor Holdings Ltd (Cartor).